ResearchMoz

Stem Cell Therapy Market in Asia-Pacific to 2018 - Commercialization Supported by Favorable Government Policies, Strong Pipeline and Increased Licensing Activity

GBI Research
Published Date » 2012-12-14
No. Of Pages » 112
     
  Stem Cell Therapy Market in Asia-Pacific to 2018 Commercialization Supported by Favorable Government Policies, Strong Pipeline and Increased Licensing Activity  
     
  Summary  
   
 GBI Research, the leading business intelligence provider, has released its latest research Stem Cell Therapy Market in Asia-Pacific to 2018 Commercialization Supported by Favorable Government Policies, Strong Pipeline and Increased Licensing Activity. The report provides an in-depth analysis on stem cell research and development in India, China, Japan, South-Korea and Singapore. The report market analysis and forecasts for CABG, LSCT, Type 1 DM, Type 2 DM, Hearticellgram, Cerecellgram, Cartistem and Cupistem. The report also provides information on trends and pipelines. In addition to this,...
Table of Contents

1 Table of Contents
1 Table of Contents 5
1.1 List of Tables 8
1.2 List of Figures 10

2 Stem Cell Therapy Market in Asia-Pacific to 2018 - Introduction 13

3 Stem Cell Therapy Market in Asia-Pacific to 2018 - Overview 14

3.1 Introduction 14
3.2 Market Characterization and Forecasts - Overview 15
3.2.1 Revenue Forecasts 15
3.2.2 Cost of Therapy 16
3.2.3 Allogeneic and Autologous Share 17
3.2.4 Stem Cell Therapy Patient Pool 18
3.3 Drivers and Barriers 19
3.3.1 Drivers 20
3.3.2 Barriers 20

4 Stem Cell Therapy Market in Asia-Pacific to 2018 - India 21
4.1 Introduction 21
4.2 Regulatory Landscape 21
4.3 Market Characterization and Forecasts - Overview 22
4.3.1 Revenue Forecasts 22
4.3.2 Cost of Therapy 23
4.3.3 Stem Cell Patient Pool 23
4.4 CABG Market Characterization and Forecasts 24
4.4.1 Introduction 24
4.4.2 Revenue Forecasts 24
4.4.3 Cost of Therapy 25
4.4.4 Stem Cell Patient Pool 26
4.5 Type 2 DM Market Characterization and Forecasts 27
4.5.1 Introduction 27
4.5.2 Revenue Forecasts 28
4.5.3 Cost of Therapy 29
4.5.4 Stem Cell Patient Pool 30
4.6 LSCT Market Characterization and Forecasts 31
4.6.1 Introduction 31
4.6.2 Revenue Forecasts 31
4.6.3 Cost of Therapy 32
4.6.4 Stem Cell Patient Pool 33

5 Stem Cell Therapy Market in Asia-Pacific to 2018 - China 34
5.1 Introduction 34
5.2 Regulatory Landscape 34
5.3 Market Characterization and Forecasts - Overview 35
5.3.1 Type 1 DM Market Characterization and Forecasts 35

6 Stem Cell Therapy Market in Asia-Pacific to 2018 - Japan 39
6.1 Introduction 39
6.2 Regulatory Landscape 39
6.3 Steroid Refractory aGvHD Market Characterization and Forecasts 41
6.3.1 Overview 41
6.3.2 Revenue Forecasts 42
6.3.3 Cost of Therapy 43
6.3.4 Stem Cell Patient Pool 44

7 Stem Cell Therapy Market in Asia-Pacific to 2018 - Singapore 45
7.1 Introduction 45
7.2 Regulatory Landscape 45
7.2.1 Ethical, Legal and Social Issues in Human Stem Cell Research, Reproductive and Therapeutic Cloning (June 2002) 46
7.2.2 Human Tissue Research (November 2002) 47
7.2.3 Research Involving Human Subjects (November 2004) 48
7.2.4 Genetic Testing and Genetic Research (November 2005) 49
7.2.5 Personal Information in Biomedical Research (May 2007) 50
7.2.6 Donation of Human Eggs for Research (November 2008) 50
7.2.7 Human-Animal Combinations in Stem Cell Research (September 2010) 50

8 Stem Cell Therapy Market in Asia-Pacific to 2018 - South Korea 51
8.1 Introduction 51
8.2 Regulatory Landscape 51
8.3 Market Characterization and Forecasts - Overview 53
8.3.1 Revenue Forecasts 53
8.3.2 Cost of Therapy 55
8.3.3 Stem Cell Patient Pool 56
8.4 Cupistem Market Characterization and Forecasts 57
8.4.1 Overview 57
8.4.2 Revenue Forecasts 58
8.4.3 Cost of Therapy 59
8.4.4 Stem Cell Patient Pool 60
8.5 HCG-AMI Market Characterization and Forecasts 61
8.5.1 Overview 61
8.5.2 Revenue Forecasts 62
8.5.3 Cost of Therapy 63
8.5.4 Stem Cell Patient Pool 64
8.6 Cartistem Market Characterization and Forecasts 65
8.6.1 Overview 65
8.6.2 Revenue Forecasts 66
8.6.3 Cost of Therapy 67
8.6.4 Stem Cell Patient Pool 68
8.7 CCG Market Characterization and Forecasts 69
8.7.1 Overview 69
8.7.2 Revenue Forecasts 69
8.7.3 Cost of Therapy 70
8.7.4 Stem Cell Patient Pool 71

9 Stem Cell Therapy Market in Asia-Pacific to 2018 - Pipeline Analysis 72
9.1 Pipeline Analysis by Phase 72
9.2 Pipeline Analysis by Sponsors/Collaborators 73
9.3 Pipeline Analysis by Country 74
9.3.1 India Stem Cell R&D Pipeline 75
9.3.2 China Stem Cell R&D Pipeline 77
9.3.3 Japan Stem Cell R&D Pipeline 81
9.3.4 Singapore Stem Cell R&D Pipeline 85
9.3.5 South Korea Stem Cell R&D Pipeline 86
9.3.6 Product Profiles of Promising Molecules 88
9.3.7 Product Profiles of Marketed Products 89

10 Stem Cell Therapy Market in Asia-Pacific to 2018 - Competitive Landscape 91
10.1 Stempeutics Research 91
10.1.1 Overview 91
10.1.2 Product Pipeline 92
10.2 Reliance Life Sciences 93
10.2.1 Overview 93
10.2.2 Product Pipeline 93
10.3 International Stem Cell Services 94
10.3.1 Overview 94
10.3.2 Product Pipeline 94
10.4 Shenzhen Beike Biotechnology 95
10.4.1 Overview 95
10.4.2 Product Pipeline 95
10.5 JCR Pharmaceuticals 96
10.5.1 Overview 96
10.5.2 Product Pipeline 96
10.6 ES Cells International (Subsidiary of BioTime, Inc) 97
10.6.1 Overview 97
10.6.2 Product Pipeline 97
10.7 Stem Cell Technologies i 98
10.7.1 Overview 98
10.7.2 Product Pipeline 98
10.8 Pharmicell 99
10.8.1 Overview 99
10.8.2 Product Pipeline 99
10.9 Medipost 100
10.9.1 Overview 100
10.9.2 Product Pipeline 100

11 Stem Cell Therapy Market in Asia-Pacific to 2018 - Strategic Consolidations 101
11.1 Overview 101
11.2 M&A Deals 102
11.2.1 RNL BIO Acquired 10% Stake in Celltex Therapeutics for $10m - October 28, 2011 102
11.2.2 BioTime Acquired ES Cell International - May 3, 2010 102
11.2.3 BCCL Acquires Stake in Life Cell - May 1, 2007 102
11.3 Licensing Deals 102
11.3.1 RNL BIO Forms Joint Venture to Develop Stem Cell Therapy - September 29, 2011 102
11.3.2 Kiadis Pharma Enters into Licensing Agreement with Hospira for ATIR - January 4, 2011 102
11.3.3 Cipla Enters into Co-Marketing Agreement with Stempeutics - April 27, 2010 102
11.3.4 Teijin Enters into Licensing Agreement with SanBio - March 2, 2010 102
11.3.5 Cleveland BioLabs Enters into Licensing Agreement with Zhejiang Hisun Pharma - September 9, 2009 103
11.3.6 Merck Signs a Licensing Agreement with Japan Tobacco - September 25, 2008 103
11.3.7 ES Cell Enters into Licensing Agreement with ITI Life Sciences - January 31, 2007 103
11.4 Co-Development Deals 103
11.4.1 JCR Pharma Enters into Co-Development Agreement with MediPal - September 13, 2011 103
11.4.2 Athersys Enters into Co-Development Agreement with Pfizer - December 21, 2009 103
11.4.3 Genzyme Enters into Agreement with Osiris Therapeutics - November 4, 2008 104
11.4.4 JCR Pharma Enters into Co-Development Agreement with Mochida Pharma - December 21, 2007 104

12 Stem Cell Therapy Market in Asia-Pacific to 2018 - Appendix 105
12.1 Market Definitions 105
12.2 Abbreviations 105
12.3 Bibliography 107
12.4 Research Methodology 108
12.4.1 Coverage 108
12.4.2 Secondary Research 108
12.4.3 Primary Research 109
12.5 Therapeutic Landscape 109
12.5.2 Market Size by Geography 111
12.6 Geographical Landscape 112
12.7 Pipeline Analysis 112
12.8 Competitive Landscape 112
12.8.1 Expert Panel Validation 112
12.9 Contact Us 112
12.10 Disclaimer 112

List of Tables


Table 1: Stem Cell Therapy Market in Asia-Pacific to 2018, Revenue Forecasts ($m), 2012-2018 15
Table 2: Stem Cell Therapy Market in Asia-Pacific to 2018, Patient Pool for Stem Cell Therapy Forecasts (000), 2012-2018 18
Table 3: Stem Cell Therapy Market in Asia-Pacific to 2018, India, Revenue Forecasts ($m), 2012-2018 22
Table 4: Stem Cell Therapy Market in Asia-Pacific to 2018, India, Patient Pool Forecasts (000), 2012-2018 23
Table 5: Stem Cell Therapy Market in Asia-Pacific to 2018, India, CABG Revenue Forecasts ($000), 2012-2018 24
Table 6: Stem Cell Therapy Market in Asia-Pacific to 2018, India, CABG Cost of Therapy Forecasts ($), 2012-2018 25
Table 7: Stem Cell Therapy Market in Asia-Pacific to 2018, India, CABG Patient Pool Forecasts (Absolute), 2012-2018 26
Table 8: Stem Cell Therapy Market in Asia-Pacific to 2018, India, Type 2 DM Revenue Forecasts ($m), 2012-2018 28
Table 9: Stem Cell Therapy Market in Asia-Pacific to 2018, India, Type 2 DM Cost of Therapy Forecasts ($), 2012-2018 29
Table 10: Stem Cell Therapy Market in Asia-Pacific to 2018, India, Type 2 DM Patient Pool Forecasts (000), 2012-2018 30
Table 11: Stem Cell Therapy Market in Asia-Pacific to 2018, India, LSCT Revenue Forecasts ($000), 2012-2018 31
Table 12: Stem Cell Therapy Market in Asia-Pacific to 2018, India, LSCT Cost of Therapy Forecasts ($), 2012-2018 32
Table 13: Stem Cell Therapy Market in Asia-Pacific to 2018, India, LSCT Patient Pool Forecasts (Absolute), 2012-2018 33
Table 14: Stem Cell Therapy Market in Asia-Pacific to 2018, China, Type 1 DM Revenue Forecasts ($m), 2012-2018 36
Table 15: Stem Cell Therapy Market in Asia-Pacific to 2018, China, Type 1 DM Cost of Therapy Forecasts ($), 2012-2018 37
Table 16: Stem Cell Therapy Market in Asia-Pacific to 2018, China, Type 1 DM Patient Pool Forecasts (000), 2012-2018 38
Table 17: Stem Cell Therapy Market in Asia-Pacific to 2018, Japan, aGvHD Revenue Forecasts ($m), 2014-2018 42
Table 18: Stem Cell Therapy Market in Asia-Pacific to 2018, Japan, aGvHD Cost of Therapy Forecasts ($), 2014-2018 43
Table 19: Stem Cell Therapy Market in Asia-Pacific to 2018, Japan, aGvHD Patient Pool for Stem Cell Therapy Forecasts (Absolute), 2014-2018 44
Table 20: Stem Cell Therapy Market in Asia-Pacific to 2018, South Korea, Revenue Forecasts ($m), 2012-2018 53
Table 21: Stem Cell Therapy Market in Asia-Pacific to 2018, South Korea, Patient Pool for Stem Cell Therapy, Forecasts (Absolute), 2012-2018 56
Table 22: Stem Cell Therapy Market in Asia-Pacific to 2018, South Korea, Cupistem Revenue Forecasts ($m), 2012-2018 58
Table 23: Stem Cell Therapy Market in Asia-Pacific to 2018, South Korea, Cupistem Cost of Therapy Forecasts ($), 2012-2018 59
Table 24: Stem Cell Therapy Market in Asia-Pacific to 2018, South Korea, Cupistem Patient Pool Forecasts (Absolute), 2012-2018 60
Table 25: Stem Cell Therapy Market in Asia-Pacific to 2018, South Korea, HCG-AMI Revenue Forecasts ($m), 2012-2018 62
Table 26: Stem Cell Therapy Market in Asia-Pacific to 2018, South Korea, HCG-AMI Cost of Therapy Forecasts ($), 2012-2018 63
Table 27: Stem Cell Therapy Market in Asia-Pacific to 2018, South Korea, HCG-AMI Patient Forecasts, 2012-2018 64
Table 28: Stem Cell Therapy Market in Asia-Pacific to 2018, South Korea, Cartistem Revenue Forecasts ($m), 2012-2018 66
Table 29: Stem Cell Therapy Market in Asia-Pacific to 2018, South Korea, Cartistem Cost of Therapy Forecasts ($), 2012-2018 67
Table 30: Stem Cell Therapy Market in Asia-Pacific to 2018, South Korea, Cartistem Patient Pool Forecasts (Absolute), 2012-2018 68
Table 31: Stem Cell Therapy Market in Asia-Pacific to 2018, South Korea, CCG Revenue Forecasts ($m), 2015-2018 69
Table 32: Stem Cell Therapy Market in Asia-Pacific to 2018, South Korea, CCG Cost of Therapy Forecasts ($), 2015-2018 70
Table 33: Stem Cell Therapy Market in Asia-Pacific to 2018, South Korea, CCG Patient Pool Forecasts (Absolute), 2015-2018 71
Table 34: Stem Cell Therapy Market in Asia-Pacific to 2018, R&D Pipeline Analysis by Phase, 2012 72
Table 35: Stem Cell Therapy Market in Asia-Pacific to 2018, R&D Pipeline Analysis by Sponsors/Collaborators, 2012 73
Table 36: Stem Cell Therapy Market in Asia-Pacific to 2018, R&D Pipeline Analysis by Country, 2012 74
Table 37: Stem Cell Therapy Market in Asia-Pacific to 2018, India, R&D Pipeline Analysis by Phase, 2012 75
Table 38: Stem Cell Therapy Market in Asia-Pacific to 2018, India, Phase II/III Pipeline Analysis, 2012 76
Table 39: Stem Cell Therapy Market in Asia-Pacific to 2018, India, Phase II Pipeline Analysis, 2012 76
Table 40: Stem Cell Therapy Market in Asia-Pacific to 2018, India, Phase I/II Pipeline Analysis, 2012 76
Table 41: Stem Cell Therapy Market in Asia-Pacific to 2018, India, Unknown Phase, 2012 76
Table 42: Stem Cell Therapy Market in Asia-Pacific to 2018, China, R&D Pipeline Analysis by Phase, 2012 77
Table 43: Stem Cell Therapy Market in Asia-Pacific to 2018, China, Post-Market Pipeline Analysis, 2012 78
Table 44: Stem Cell Therapy Market in Asia-Pacific to 2018, China, Phase II Pipeline Analysis, 2012 78
Table 45: Stem Cell Therapy Market in Asia-Pacific to 2018, China, Phase I/II Pipeline Analysis, 2012 79
Table 46: Stem Cell Therapy Market in Asia-Pacific to 2018, China, Phase I Pipeline Analysis, 2012 79
Table 47: Stem Cell Therapy Market in Asia-Pacific to 2018, China, Clinical Pre-Test Pipeline Analysis, 2012 80
Table 48: Stem Cell Therapy Market in Asia-Pacific to 2018, China, Unknown Phase, 2012 80
Table 49: Stem Cell Therapy Market in Asia-Pacific to 2018, Japan, R&D Pipeline Analysis by Phase, 2012 81
Table 50: Stem Cell Therapy Market in Asia-Pacific to 2018, Japan, Phase III Stage Molecules Pipeline Analysis, 2012 82
Table 51: Stem Cell Therapy Market in Asia-Pacific to 2018, Japan, Phase II/III Stage Molecules Pipeline Analysis, 2012 82
Table 52: Stem Cell Therapy Market in Asia-Pacific to 2018, Japan, Phase II Stage Molecules Pipeline Analysis, 2012 83
Table 53: Stem Cell Therapy Market in Asia-Pacific to 2018, Japan, Phase I/II Stage Molecules Pipeline Analysis, 2012 84
Table 54: Stem Cell Therapy Market in Asia-Pacific to 2018, Japan, Phase I Stage Molecules Pipeline Analysis, 2012 84
Table 55: Stem Cell Therapy Market in Asia-Pacific to 2018, Singapore, Phase I/II Stage Molecules Pipeline Analysis, 2012 85
Table 56: Stem Cell Therapy Market in Asia-Pacific to 2018, South Korea, R&D Pipeline Analysis by Phase, 2012 86
Table 57: Stem Cell Therapy Market in Asia-Pacific to 2018, South Korea, Phase III Molecules Pipeline Analysis, 2012 87
Table 58: Stem Cell Therapy Market in Asia-Pacific to 2018, South Korea, Phase II/III Molecules Pipeline Analysis, 2012 87
Table 59: Stem Cell Therapy Market in Asia-Pacific to 2018, South Korea, Phase II Molecules Pipeline Analysis, 2012 87
Table 60: Stem Cell Therapy Market in Asia-Pacific to 2018, South Korea, Phase I/II Molecules Pipeline Analysis, 2012 87
Table 61: Stem Cell Therapy Market in Asia-Pacific to 2018, South Korea, Phase I Molecules Pipeline Analysis, 2012 88
Table 62: Stem Cell Therapy Market in Asia-Pacific to 2018, South Korea, Unknown Phase, 2012 88
Table 63: Stem Cell Therapy Market in Asia-Pacific to 2018, Stempeutics, R&D Pipeline, 2012 92
Table 64: Stem Cell Therapy Market in Asia-Pacific to 2018, Reliance Life Sciences, R&D Pipeline, 2012 93
Table 65: Stem Cell Therapy Market in Asia-Pacific to 2018, International Stem Cell Services Limited, R&D Pipeline, 2012 94
Table 66: Stem Cell Therapy Market in Asia-Pacific to 2018, Shenzhen Beike Biotechnology R&D Pipeline, 2012 95
Table 67: Stem Cell Therapy Market in Asia-Pacific to 2018, JCR Pharmaceuticals Co. Ltd, R&D Pipeline, 2012 96
Table 68: Stem Cell Therapy Market in Asia-Pacific to 2018, Pharmicell, R&D Pipeline, 2012 99
Table 69: Stem Cell Therapy Market in Asia-Pacific to 2018, Medipost, R&D Pipeline, 2012 100
Table 70: Stem Cell Therapy Market in Asia-Pacific to 2018, Strategic Consolidations Overview, 2007-2012 101

List of Figures


Figure 1: Stem Cell Therapy Market in Asia-Pacific to 2018, Overview, 2012 14
Figure 2: Stem Cell Therapy Market in Asia-Pacific to 2018, Revenue Forecasts ($m), 2012-2018 15
Figure 3: Stem Cell Therapy Market in Asia-Pacific to 2018, Cost of Therapy Overview ($), 2012 16
Figure 4: Stem Cell Therapy Market in Asia-Pacific to 2018, Allogeneic vs. Autologous (%), 2012 17
Figure 5: Stem Cell Therapy Market in Asia-Pacific to 2018, Patient Pool for Stem Cell Therapy Forecasts (000), 2012-2018 18
Figure 6: Stem Cell Therapy Market in Asia-Pacific to 2018, Drivers and Barriers, 2012 19
Figure 7: Stem Cell Therapy Market in Asia-Pacific to 2018, India, Revenue Forecasts ($m), 2012-2018 22
Figure 8: Stem Cell Therapy Market in Asia-Pacific to 2018, India, Cost of Therapy Overview ($), 2012 23
Figure 9: Stem Cell Therapy Market in Asia-Pacific to 2018, India, Patient Pool Forecasts (000), 2012-2018 23
Figure 10: Stem Cell Therapy Market in Asia-Pacific to 2018, India, CABG Revenue Forecasts ($000), 2012-2018 24
Figure 11: Stem Cell Therapy Market in Asia-Pacific to 2018, India, CABG Cost of Therapy Forecasts ($), 2012-2018 25
Figure 12: Stem Cell Therapy Market in Asia-Pacific to 2018, India, CABG Patient Pool Forecasts (Absolute), 2012-2018 26
Figure 13: Stem Cell Therapy Market in Asia-Pacific to 2018, India, Type 2 DM Revenue Forecasts ($m), 2012-2018 28
Figure 14: Stem Cell Therapy Market in Asia-Pacific to 2018, India, Type 2 DM Cost of Therapy Forecasts ($), 2012-2018 29
Figure 15: Stem Cell Therapy Market in Asia-Pacific to 2018, India, Type 2 DM Patient Pool Forecasts (000), 2012-2018 30
Figure 16: Stem Cell Therapy Market in Asia-Pacific to 2018, India, LSCT Revenue Forecasts ($000), 2012-2018 31
Figure 17: Stem Cell Therapy Market in Asia-Pacific to 2018, India, LSCT Cost of Therapy Forecasts ($), 2012-2018 32
Figure 18: Stem Cell Therapy Market in Asia-Pacific to 2018, India, LSCT Patient Pool Forecasts (Absolute), 2012-2018 33
Figure 19: Stem Cell Therapy Market in Asia-Pacific to 2018, China, Regulatory Framework Timeline, 1998-2009 34
Figure 20: Stem Cell Therapy Market in Asia-Pacific to 2018, China, Type 1 DM Revenue Forecasts ($m), 2012-2018 36
Figure 21: Stem Cell Therapy Market in Asia-Pacific to 2018, China, Type 1 DM Cost of Therapy Forecasts ($), 2012-2018 37
Figure 22: Stem Cell Therapy Market in Asia-Pacific to 2018, China, Type 1 DM Patient Pool Forecasts (000), 2012-2018 38
Figure 23: Stem Cell Therapy Market in Asia-Pacific to 2018, Japan, MHLW Stem Cell Guidelines, 2010 39
Figure 24: Stem Cell Therapy Market in Asia-Pacific to 2018, Japan, JR-031 Overview, 2012 41
Figure 25: Stem Cell Therapy Market in Asia-Pacific to 2018, Japan, aGvHD Revenue Forecasts ($m), 2014-2018 42
Figure 26: Stem Cell Therapy Market in Asia-Pacific to 2018, Japan, aGvHD Cost of Therapy Forecasts ($), 2014-2018 43
Figure 27: Stem Cell Therapy Market in Asia-Pacific to 2018, Japan, aGvHD Patient Pool for Stem Cell Therapy Forecasts (Absolute), 2014-2018 44
Figure 28: Stem Cell Therapy Market in Asia-Pacific to 2018, South Korea, Stem Cell Therapeutics Approval Process, 2011 51
Figure 29: Stem Cell Therapy Market in Asia-Pacific to 2018, South Korea, Biopharmaceutical Implementation Strategies, 2011 52
Figure 30: Stem Cell Therapy Market in Asia-Pacific to 2018, South Korea, Revenue Forecasts ($m), 2012-2018 53
Figure 31: Stem Cell Therapy Market in Asia-Pacific to 2018, South Korea, Autologous and Allogeneic Share (%), 2012 54
Figure 32: Stem Cell Therapy Market in Asia-Pacific to 2018, South Korea, Marketed Products Share (%), 2012 and 2018 54
Figure 33: Stem Cell Therapy Market in Asia-Pacific to 2018, South Korea, Cost of Therapy ($), Overview, 2012 55
Figure 34: Stem Cell Therapy Market in Asia-Pacific to 2018, South Korea, Patient Pool for Stem Cell Therapy, Forecasts (Absolute), 2012-2018 56
Figure 35: Stem Cell Therapy Market in Asia-Pacific to 2018, South Korea, Cupistem Revenue Forecasts ($m), 2012-2018 58
Figure 36: Stem Cell Therapy Market in Asia-Pacific to 2018, South Korea, Cupistem Cost of Therapy Forecasts ($), 2012-2018 59
Figure 37: Stem Cell Therapy Market in Asia-Pacific to 2018, South Korea, Cupistem Patient Pool Forecasts (Absolute), 2012-2018 60
Figure 38: Stem Cell Therapy Market in Asia-Pacific to 2018, South Korea, HCG-AMI Revenue Forecasts ($m), 2012-2018 62
Figure 39: Stem Cell Therapy Market in Asia-Pacific to 2018, South Korea, HCG-AMI Cost of Therapy Forecasts ($), 2012-2018 63
Figure 40: Stem Cell Therapy Market in Asia-Pacific to 2018, South Korea, HCG-AMI Patient Forecasts (Absolute), 2012-2018 64
Figure 41: Stem Cell Therapy Market in Asia-Pacific to 2018, South Korea, Cartistem Revenue Forecasts ($m), 2012-2018 66
Figure 42: Stem Cell Therapy Market in Asia-Pacific to 2018, South Korea, Cartistem Cost of Therapy Forecasts ($), 2012-2018 67
Figure 43: Stem Cell Therapy Market in Asia-Pacific to 2018, South Korea, Cartistem Patient Pool Forecasts (Absolute), 2012-2018 68
Figure 44: Stem Cell Therapy Market in Asia-Pacific to 2018, South Korea, CCG Revenue Forecasts ($m), 2015-2018 69
Figure 45: Stem Cell Therapy Market in Asia-Pacific to 2018, South Korea, CCG Cost of Therapy Forecasts ($), 2015-2018 70
Figure 46: Stem Cell Therapy Market in Asia-Pacific to 2018, South Korea, CCG Patient Pool Forecasts (Absolute), 2015-2018 71
Figure 47: Stem Cell Therapy Market in Asia-Pacific to 2018, R&D Pipeline Analysis by Phase (%), 2012 72
Figure 48: Stem Cell Therapy Market in Asia-Pacific to 2018, R&D Pipeline Analysis by Sponsors/Collaborators (%), 2012 73
Figure 49: Stem Cell Therapy Market in Asia-Pacific to 2018, R&D Pipeline Analysis by Country (%), 2012 74
Figure 50: Stem Cell Therapy Market in Asia-Pacific to 2018, India, R&D Pipeline Analysis by Phase (%), 2012 75
Figure 51: Stem Cell Therapy Market in Asia-Pacific to 2018, China, R&D Pipeline Analysis by Phase (%), 2012 77
Figure 52: Stem Cell Therapy Market in Asia-Pacific to 2018, Japan, R&D Pipeline Analysis by Phase (%), 2012 81
Figure 53: Stem Cell Therapy Market in Asia-Pacific to 2018, South Korea, R&D Pipeline Analysis by Phase (%), 2012 86
Figure 54: Stem Cell Therapy Market in Asia-Pacific to 2018, Stempeutics, Overview, 2012 91
Figure 55: Stem Cell Therapy Market in Asia-Pacific to 2018, Reliance Life Sciences, Overview, 2012 93
Figure 56: Stem Cell Therapy Market in Asia-Pacific to 2018, International Stem Cell Services, Overview, 2012 94
Figure 57: Stem Cell Therapy Market in Asia-Pacific to 2018, Shenzhen Beike Biotechnology Overview, 2012 95
Figure 58: Stem Cell Therapy Market in Asia-Pacific to 2018, JCR Pharmaceuticals Overview, 2012 96
Figure 59: Stem Cell Therapy Market in Asia-Pacific to 2018, ES Cells International, Overview, 2012 97
Figure 60: Stem Cell Therapy Market in Asia-Pacific to 2018, Stem Cell Technologies i, Overview, 2012 98
Figure 61: Stem Cell Therapy Market in Asia-Pacific to 2018, Pharmicell Overview, 2012 99
Figure 62: Stem Cell Therapy Market in Asia-Pacific to 2018, Medipost, Overview, 2012 100
Figure 63: Stem Cell Therapy Market in Asia-Pacific to 2018, Strategic Consolidations Overview (%), 2007-2012 101
Figure 64: GBI Research Market Forecasting Model 111

Upcoming Reports:

Specialty Oilfield Chemical Market- Global And China Forecast, Market Share, Size, Growth And Industry Analysis (2010-2017)
By - Transparency Market Research
Specialty chemicals are sold on the basis of their performance rather than their chemical composition of single entity or complex composition. Intense knowledge is required to deliver products and services in the specialty chemicals segment. Due to which specialty chemical vendors produced higher sales volume and revenues in 2010 with an increase in the production cost as well. Major segments of specialty chemicals include specialty polymers, industrial and institutional cleaners, pesticides, electronic chemicals and construction chemicals altogether contributing 38% of the overall...
Orthopedic Trauma Fixation Device Market - Global Industry Analysis, Size, Share, Growth, Trends And Forecast, 2013 - 2019
By - Transparency Market Research
Orthopedic is a branch of medical science which deals with the disorders or deformities caused to bone, spine and joint. Orthopedic trauma can be defined as it is a severe injury to the musculoskeletal system such as ligament, joint and bone. Orthopedic trauma needs an immediate treatment and in sometimes it creates a medical emergency.  The global market for orthopedic trauma fixation device can be segmented as  by device type internal orthopedic trauma fixation device external orthopedic trauma fixation device Car and bike accident are...
Poland: market of cold rolled sheets and plates
By - Williams and Marshal Strategy
This report presents a comprehensive overview of the cold rolled sheets and plates market in Poland and its state as of January 2014. It provides detailed analysis of the industry, its dynamics and structure. The purpose of the report is to describe the state of the cold rolled sheets and plates market in Poland, to present actual and retrospective information about the volumes and dynamics of production, imports, exports and consumption, the characteristics of the market for the period 2008-2012 and to build a forecast for the market development until 2018. In the same way, the report...

Research Assistance

We will be happy to help you find what you need.
Please call us or write us:

866-997-4948 (Us-Canada Toll Free)
Tel: +1-518-618-1030
Email: sales@researchmoz.us
Select License type:

Share this report

Related News

Export market in New Zealand driven by innovative and high-value food products
Jul 29, 2014  
Demand for beverages and high value foods in Asia are driving the food and beverage industry in New Zealand. Also there is high demand for dairy products, seafood, meat and processed foods in the Asian economies which fuel the give an export boost to the economy of New Zealand.  Asia has a rapidly growing market for food which in turn is highly beneficial for New Zealand’s export...
Sony plans revival of PlayStation with network services
Jul 29, 2014  
After a nearly USD 10 billion loss over the last six years, Sony Corp has plans of reviving its consumer electronics hero – the PlayStation. Sony will be repositioning the video game console as a center of streamed network services such as social media, music and movies apart from games. The matter is still in its infancy stage of discussion and the plan is to generate revenue from the...
OnePlus One ready to launch it smart phone in India
Jul 28, 2014  
Chinese smart phones are gaining popularity in the Indian market. OnePlus, a Chinese smart phones company, is ready to launch the invitation-only One smart phone in India.  Many Chinese smart phone brands have got inspired by the success of another smart phone brand called Xiaomi which had successfully launched the Mi 3, a smart phone in the Indian market. The OnePlus One is a typical...
Danone all set to sell its business to Hospira
Jul 28, 2014  
According to the Financial Times, Danone, a French dairy group is aiming at selling its business pertaining to medical nutrition to Hospira, a US group. The deal value is estimated at $ 5 billion.  The plan is still in the pipeline as nothing with respect to the business is fully confirmed or certain. Representatives of neither business groups were willing to comment on the same. ...
At a USD 62 Price Tag, the Karbonn A50S Smartphone Could Challenge Likes of Apple and Samsung in India
Jul 28, 2014  
A USD 62 smartphone launched in the Indian market by Karbonn could signal stiff competition for behemoths such as Apple that makes the iPhone and Samsung, known best for its Galaxy smartphone range. The Karbonn A50S, which has been officially launched in India, can also be ordered by customers outside of the country via online stores, and delivered to their doorstep. Given its exceptionally...